Compounds and methods for modulating desmosomal cadherin-mediated functions
AssigneeAdherex Technologies, Inc.
InventorsOrest W. Blaschuk, James Matthew Symonds, Barbara J. Gour
Life of this patent
Estimating the term…
Loading patent…
AssigneeAdherex Technologies, Inc.
InventorsOrest W. Blaschuk, James Matthew Symonds, Barbara J. Gour
Estimating the term…
Modulating agents for inhibiting or enhancing desmosomal cadherin mediated cell adhesion are provided. The modulating agents comprise one or more of: (a) a peptide sequence that is at least 50% identical to a desmosomal cadherin CAR sequence; (b) a non-peptide mimetic of a desmosomal cadherin CAR sequence; (c) a substance, such as an antibody or antigen-binding fragment thereof, that specifically binds a desmosomal cadherin CAR sequence; and/or (d) a polynucleotide encoding a polypeptide that comprises a desmosomal cadherin CAR sequence or analogue thereof. Methods for using such modulating agents for modulating desmosomal cadherin-mediated cell adhesion in a variety of contexts are also provided.
A modulating agent that:
(Canceled)
A modulating agent that:
(Canceled)
A modulating agent that comprises a desmosomal cadherin CAR sequence selected from the group consisting of NQK, NRN, NKD, EKD, ERD, RAL, YAL, YAT, FAT and YAS, wherein the agent contains no more than 50 consecutive amino acid residues present within a desmosomal cadherin.
A modulating agent comprising an antibody or antigen-binding fragment thereof that specifically binds to a desmosomal cadherin CAR sequence and modulates a desmosomal cadherin-mediated function, wherein the desmosomal cadherin CAR sequence has the formula:
(Canceled)
A modulating agent comprising an antibody or antigen-binding fragment thereof that:
A modulating agent comprising an antibody or antigen-binding fragment thereof that:
25-31. (Canceled)
33-39. (Canceled)
45-70. (Canceled)
Dependencies are inferred from the claim text.